Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery

SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery

CointurkCointurk2026/09/14 06:39
By:Cointurk

The Sui (SUI) token is trading near $0.72, showing a 4% drop over the past 24 hours and a 7% decline for the week. Despite this recent weakness, SUI remains up around 5% for the month, according to market activity tracked by major crypto data platforms.

Key support levels face market pressure

Traders are closely watching the $0.70–$0.71 support range, which many view as pivotal for the token’s short-term outlook. If this level remains intact, several analysts expect a rebound towards $0.84 or higher. However, a close below $0.71 could trigger further declines, potentially targeting the $0.62–$0.63 zone.

Technical trader Bitguru described $0.70 as a “critical inflection point.” In his assessment, a sustained bounce from current support could see SUI test $0.85, with further upside possible to $0.92 if buyer momentum returns.

Ali Martinez, a well-known cryptocurrency analyst, echoed this sentiment. Martinez indicated that he would consider re-entering a long position if SUI holds above $0.71, anticipating a price move towards $0.84.

Martinez referenced a TD Sequential buy signal that previously triggered a 17% rally, stating, “now, with $SUI trading near $0.71, the indicator has flashed a fresh buy signal.”

The TD Sequential indicator, frequently used by technical traders, is designed to identify potential trend reversals or significant momentum changes.

Mini dictionary: TD Sequential, a technical analysis indicator that attempts to identify potential trend exhaustion and predict a possible reversal by counting consecutive price bars in a certain direction.

Prominent trader Michaël van de Poppe also signaled optimism regarding the support level, suggesting that a successful retest and rebound could see SUI challenge $0.85 and possibly return to values above $1.

The convergence of several independent analysts around the $0.70–$0.71 support range and the $0.84–$0.85 resistance range adds weight to these crucial price levels for SUI in the near term.

Currently, derivatives trading volume in SUI outpaces spot trading, a trend that could increase short-term volatility due to the potential for sudden liquidations of highly leveraged positions.

Institutional expansion and network metrics

Institutional interest in Sui has grown following the launch of the 21Shares Sui ETF (TSUI) on Nasdaq in February 2026, alongside new SUI futures contracts from CME Group introduced in May. These products have expanded access to the token for a broader range of professional investors.

On-chain activity on the Sui network has also reached notable milestones. The blockchain has processed more than 16.1 billion transactions. The stablecoin market capitalization within the Sui ecosystem climbed to $463 million this week, with USDC representing roughly two-thirds of that total.

The Sui Foundation has been actively supporting the network and token price by buying back over 609,800 SUI so far in 2026. These repurchased tokens are funded by stablecoin revenues generated on-chain and are reintroduced into the ecosystem rather than destroyed.

Sui continues with scheduled monthly unlocks of about 64 million tokens, contributing to an increasing circulating supply. The network currently lists 4.09 billion SUI available to trade, with a total cap set at 10 billion tokens.

Mini dictionary: Sui Foundation, a non-profit organization responsible for supporting the development, ecosystem growth, and community initiatives related to the Sui blockchain.

Metric Current Value
SUI price $0.72
Key support $0.70–$0.71
Resistance target $0.84–$0.85
30-day performance +5%
Monthly unlock ~64 million SUI
Circulating supply 4.09 billion SUI
Total supply cap 10 billion SUI
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales